| Literature DB >> 26910103 |
Lisa Zondler1, Kathrin Müller1, Samira Khalaji2, Corinna Bliederhäuser1, Wolfgang P Ruf1, Veselin Grozdanov1, Meinolf Thiemann3, Katrin Fundel-Clemes4, Axel Freischmidt1, Karlheinz Holzmann5, Benjamin Strobel4, Patrick Weydt1, Anke Witting1, Dietmar R Thal1, Anika M Helferich1, Bastian Hengerer4, Kay-Eberhard Gottschalk2, Oliver Hill3, Michael Kluge3, Albert C Ludolph1, Karin M Danzer1, Jochen H Weishaupt6.
Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disease affecting primarily the upper and lower motor neurons. A common feature of all ALS cases is a well-characterized neuroinflammatory reaction within the central nervous system (CNS). However, much less is known about the role of the peripheral immune system and its interplay with CNS resident immune cells in motor neuron degeneration. Here, we characterized peripheral monocytes in both temporal and spatial dimensions of ALS pathogenesis. We found the circulating monocytes to be deregulated in ALS regarding subtype constitution, function and gene expression. Moreover, we show that CNS infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic ALS mouse model. Furthermore, application of human immunoglobulins or fusion proteins containing only the human Fc, but not the Fab antibody fragment, increased CNS invasion of peripheral monocytes and delayed the disease onset. Our results underline the importance of peripheral monocytes in ALS pathogenesis and are in agreement with a protective role of monocytes in the early phase of the disease. The possibility to boost this beneficial function of peripheral monocytes by application of human immunoglobulins should be evaluated in clinical trials.Entities:
Keywords: Amyotrophic lateral sclerosis; Fc receptor; Immunoglobulin; Innate immunity; Microglia; Monocyte
Mesh:
Year: 2016 PMID: 26910103 DOI: 10.1007/s00401-016-1548-y
Source DB: PubMed Journal: Acta Neuropathol ISSN: 0001-6322 Impact factor: 17.088